Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.

Jarrod D. Knudson, Gregory A. Payne, Léna Borbouse, Johnathan Tune

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Leptin, a product of the obesity gene, is a molecule that has received much attention since its cloning in 1994. Initially, most work centered around the effects of leptin on satiety and energy balance. However, in recent years there has been an intense focus on leptin as it relates to the cardiovascular system. Plasma leptin concentration is markedly elevated in obesity and the metabolic syndrome, both of which are associated with increased incidence of cardiovascular pathologies. In many studies, hyperleptinemia has been linked to endothelial dysfunction (a known precursor to atherosclerotic cardiovascular disease) and activation of the sympathetic nervous system. Additionally, recent evidence suggests that leptin released from perivascular adipose tissue may also have deleterious effects on the underlying vasculature, including the coronary circulation. This report reviews pertinent literature on leptin-mediated endothelial dysfunction, leptin-mediated sympathetic activation, and leptin as a significant perivascular adipose-derived factor.

Original languageEnglish (US)
Pages (from-to)434-439
Number of pages6
JournalCurrent Hypertension Reports
Volume10
Issue number6
DOIs
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

Leptin
Cardiovascular Diseases
Obesity
Coronary Circulation
Sympathetic Nervous System
Cardiovascular System
Adipose Tissue
Organism Cloning
Pathology
Incidence
Genes

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. / Knudson, Jarrod D.; Payne, Gregory A.; Borbouse, Léna; Tune, Johnathan.

In: Current Hypertension Reports, Vol. 10, No. 6, 12.2008, p. 434-439.

Research output: Contribution to journalArticle

Knudson, Jarrod D. ; Payne, Gregory A. ; Borbouse, Léna ; Tune, Johnathan. / Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. In: Current Hypertension Reports. 2008 ; Vol. 10, No. 6. pp. 434-439.
@article{981376dbc1c341aabe9ca148bbe31df4,
title = "Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.",
abstract = "Leptin, a product of the obesity gene, is a molecule that has received much attention since its cloning in 1994. Initially, most work centered around the effects of leptin on satiety and energy balance. However, in recent years there has been an intense focus on leptin as it relates to the cardiovascular system. Plasma leptin concentration is markedly elevated in obesity and the metabolic syndrome, both of which are associated with increased incidence of cardiovascular pathologies. In many studies, hyperleptinemia has been linked to endothelial dysfunction (a known precursor to atherosclerotic cardiovascular disease) and activation of the sympathetic nervous system. Additionally, recent evidence suggests that leptin released from perivascular adipose tissue may also have deleterious effects on the underlying vasculature, including the coronary circulation. This report reviews pertinent literature on leptin-mediated endothelial dysfunction, leptin-mediated sympathetic activation, and leptin as a significant perivascular adipose-derived factor.",
author = "Knudson, {Jarrod D.} and Payne, {Gregory A.} and L{\'e}na Borbouse and Johnathan Tune",
year = "2008",
month = "12",
doi = "10.1007/s11906-008-0082-2",
language = "English (US)",
volume = "10",
pages = "434--439",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "6",

}

TY - JOUR

T1 - Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.

AU - Knudson, Jarrod D.

AU - Payne, Gregory A.

AU - Borbouse, Léna

AU - Tune, Johnathan

PY - 2008/12

Y1 - 2008/12

N2 - Leptin, a product of the obesity gene, is a molecule that has received much attention since its cloning in 1994. Initially, most work centered around the effects of leptin on satiety and energy balance. However, in recent years there has been an intense focus on leptin as it relates to the cardiovascular system. Plasma leptin concentration is markedly elevated in obesity and the metabolic syndrome, both of which are associated with increased incidence of cardiovascular pathologies. In many studies, hyperleptinemia has been linked to endothelial dysfunction (a known precursor to atherosclerotic cardiovascular disease) and activation of the sympathetic nervous system. Additionally, recent evidence suggests that leptin released from perivascular adipose tissue may also have deleterious effects on the underlying vasculature, including the coronary circulation. This report reviews pertinent literature on leptin-mediated endothelial dysfunction, leptin-mediated sympathetic activation, and leptin as a significant perivascular adipose-derived factor.

AB - Leptin, a product of the obesity gene, is a molecule that has received much attention since its cloning in 1994. Initially, most work centered around the effects of leptin on satiety and energy balance. However, in recent years there has been an intense focus on leptin as it relates to the cardiovascular system. Plasma leptin concentration is markedly elevated in obesity and the metabolic syndrome, both of which are associated with increased incidence of cardiovascular pathologies. In many studies, hyperleptinemia has been linked to endothelial dysfunction (a known precursor to atherosclerotic cardiovascular disease) and activation of the sympathetic nervous system. Additionally, recent evidence suggests that leptin released from perivascular adipose tissue may also have deleterious effects on the underlying vasculature, including the coronary circulation. This report reviews pertinent literature on leptin-mediated endothelial dysfunction, leptin-mediated sympathetic activation, and leptin as a significant perivascular adipose-derived factor.

UR - http://www.scopus.com/inward/record.url?scp=58949091779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58949091779&partnerID=8YFLogxK

U2 - 10.1007/s11906-008-0082-2

DO - 10.1007/s11906-008-0082-2

M3 - Article

VL - 10

SP - 434

EP - 439

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 6

ER -